Neurophysiological Predictors of Response to Medication in Parkinson's Disease

Código QR

Neurophysiological Predictors of Response to Medication in Parkinson's Disease

Background: Although dopaminergic medication has been the foundation of Parkinson's disease (PD) therapy for decades, sensitive and specific therapeutic response biomarkers that allow for better treatment optimization are lacking.Objective: We tested whether the features of Transcranial Magneti...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Saša R. Filipović, Aleksandra Kačar, Sladjan Milanović, Miloš R. Ljubisavljević
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	Parkinson's disease TMS paired pulse TMS cortical inhibition dopaminergic therapy personalized therapy Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/0a00036df85149208d1ed2b38c5519b9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Effect of Pulse Duration and Direction on Plasticity Induced by 5 Hz Repetitive Transcranial Magnetic Stimulation in Correlation With Neuronal Depolarization
por: Islam Halawa, et al.
Publicado: (2021)

Spontaneous Fluctuations in Oscillatory Brain State Cause Differences in Transcranial Magnetic Stimulation Effects Within and Between Individuals
por: Shanice E. W. Janssens, et al.
Publicado: (2021)

Neuroprotective Potential of Polydatin Against Motor Abnormalities and Dopaminergic Neuronal Loss in Rotenone Induced Parkinson Model
por: Ahmed,Muhammad Rashid, et al.
Publicado: (2018)

Are We Right about the Right TPJ? A Review of Brain Stimulation and Social Cognition in the Right Temporal Parietal Junction
por: Nathira Ahmad, et al.
Publicado: (2021)

Efficacy of Repetitive Transcranial Magnetic Stimulation for Acute Central Post-stroke Pain: A Case Study
por: Calogero Malfitano, et al.
Publicado: (2021)

TMS-EEG Biomarkers of Amnestic Mild Cognitive Impairment Due to Alzheimer’s Disease: A Proof-of-Concept Six Years Prospective Study
por: Florinda Ferreri, et al.
Publicado: (2021)

TMS and CBT-I for comorbid depression and insomnia. Exploring feasibility and tolerability of transcranial magnetic stimulation (TMS) and cognitive behavioral therapy for insomnia (CBT-I) for comorbid major depressive disorder and insomnia during the COVID-19 pandemic
por: Michael A. Norred, et al.
Publicado: (2021)

Autophagy Inhibitor 3-Methyladenine could not Modulate Rotenone Neurotoxicity in Primary Mesencephalic Cell Culture
por: Radad,Khaled, et al.
Publicado: (2020)

Pharmacological methods of therapy in Parkinson’s disease
por: Y. N. Bykov, et al.
Publicado: (2016)

Transcranial magnetic stimulation in the treatment of obsessive–compulsive disorder: current perspectives
por: Lusicic A, et al.
Publicado: (2018)

TFE3-Mediated Autophagy is Involved in Dopaminergic Neurodegeneration in Parkinson’s Disease
por: Xin He, et al.
Publicado: (2021)

Cortical function in Alzheimer’s disease and frontotemporal dementia
por: Wang Pan, et al.
Publicado: (2016)

Implementation of PPI with Nano Amorphous Oxide Semiconductor Devices for Medical Applications
por: Dai M, et al.
Publicado: (2020)

Implementation of PPI with Nano Amorphous Oxide Semiconductor Devices for Medical Applications [Corrigendum]
por: Dai M, et al.
Publicado: (2020)

Evaluation of the Association Between Serum Levels of Testosterone and Prolactin With 6- Hydroxydopamine- Induced Parkinsonism in Male Rats
por: Roghaieh Razaghi, et al.
Publicado: (2021)

Implications of Transcranial Magnetic Stimulation as a Treatment Modality for Tinnitus
por: Alexa J. Denton, et al.
Publicado: (2021)

A New Paired Associative Stimulation Protocol with High-Frequency Peripheral Component and High-Intensity 20 Hz Repetitive Transcranial Magnetic Stimulation—A Pilot Study
por: Sabin Sathyan, et al.
Publicado: (2021)

Music Therapy and Parkinson’s Disease: A Systematic Review from 2015–2020
por: Manuel Joaquín Machado Sotomayor, et al.
Publicado: (2021)

Triggering Receptor Expressed on Myeloid Cells 2 Protects Dopaminergic Neurons by Promoting Autophagy in the Inflammatory Pathogenesis of Parkinson’s Disease
por: Wei Huang, et al.
Publicado: (2021)

Successful treatment of the Meige's syndrome with navigated repetitive transcranial magnetic stimulation: A case report
por: Chang-Geng Song, et al.
Publicado: (2022)

Editorial: New Advances in Diagnostic Tools and Rehabilitation of Disorders of Consciousness in the Acute Phase
por: Alessandro Pincherle, et al.
Publicado: (2021)

The relationship between pre-treatment heart rate variability and response to low-frequency accelerated repetitive transcranial magnetic stimulation in major depression
por: Jean-Philippe Miron, et al.
Publicado: (2021)

Successful suppression of musical hallucinations with low-frequency rTMS of the left temporo-parietal junction: A case report
por: Janne Nordberg, et al.
Publicado: (2021)

Aplicaciones de la musicoterapia en la medicina
por: Zárate D,Patricia, et al.
Publicado: (2001)

Gene Therapeutic Approaches for the Treatment of Mitochondrial Dysfunction in Parkinson’s Disease
por: Jannik Prasuhn, et al.
Publicado: (2021)

Mobile computer technologies in personified therapy of Parkinson’s disease patients
por: Y. N. Bykov, et al.
Publicado: (2018)

The Brain Electrophysiological recording & STimulation (BEST) toolbox
por: Umair Hassan, et al.
Publicado: (2022)

Development of an Advanced Sham Coil for Transcranial Magnetic Stimulation and Examination of Its Specifications
por: Mayuko Takano, et al.
Publicado: (2021)

Predicting the Extent of Resection of Motor-Eloquent Gliomas Based on TMS-Guided Fiber Tracking
por: Francesco Belotti, et al.
Publicado: (2021)

Safinamide: an add-on treatment for managing Parkinson’s disease
por: Müller T
Publicado: (2018)

USE OF TRANSCRANIAL MAGNETIC STIMULATION IN CHILDREN WITH CONSEQUENCES OF PERINATAL BRAIN LESIONS
por: S. Y. Lavrik, et al.
Publicado: (2016)

Effects of dopaminergic drug adjustment on executive function in different clinical stages of Parkinson’s disease
por: Murakami H, et al.
Publicado: (2017)

Fyn kinase regulates dopaminergic neuronal apoptosis in animal and cell models of high glucose (HG) treatment
por: Changhong Tan, et al.
Publicado: (2021)

Role of G Protein-Coupled Receptors in Microglial Activation: Implication in Parkinson’s Disease
por: Chao Gu, et al.
Publicado: (2021)

The Neuro-Protective Effects of the TSPO Ligands CB86 and CB204 on 6-OHDA-Induced PC12 Cell Death as an In Vitro Model for Parkinson’s Disease
por: Sheelu Monga, et al.
Publicado: (2021)

Anatomical and fMRI-network comparison of multiple DLPFC targeting strategies for repetitive transcranial magnetic stimulation treatment of depression
por: V.A. Cardenas, et al.
Publicado: (2022)

Parkinson's disease

Phase synchronized 6 Hz transcranial electric and magnetic stimulation boosts frontal theta activity and enhances working memory
por: Tiam Hosseinian, et al.
Publicado: (2021)

Predictive models for response to non-invasive brain stimulation in stroke: A critical review of opportunities and pitfalls
por: Maximilian J. Wessel, et al.
Publicado: (2021)

Increased migraine-free intervals with multifocal repetitive transcranial magnetic stimulation
por: Pavel Leahu, et al.
Publicado: (2021)